{
  "links": "https://www.ycombinator.com/companies/nanograb",
  "name": "Nanograb",
  "headline": "AI-generated binders for targeted drug delivery",
  "batch": "S23",
  "description": "Nanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases. Our product allows drugs to be targeted to very specific areas of the body.",
  "activity_status": "Active",
  "website": "https://nanograb.com",
  "founded_date": 2023.0,
  "team_size": 3.0,
  "location": "San Francisco",
  "group_partner": null,
  "group_partner_yc": null,
  "company_linkedin": null,
  "company_twitter": null,
  "tags": "industry:ai-powered-drug-discovery; industry:nanomedicine; industry:biotech; industry:drug-delivery; industry:therapeutics; location:san-francisco-bay-area",
  "founders": [
    {
      "name": "Debesh Mandal, Founder",
      "description": "Co-founder and CEO of Nanograb. PhD in Computational Biophysics from Imperial College London. Experienced in molecular simulations and building software for scientists. First software hire at Fabricnano",
      "linkedin": "https://linkedin.com/in/debeshmandal"
    },
    {
      "name": "Christopher Lau, Founder",
      "description": "Co-founder of Nanograb. M.Eng Biomaterials and Tissue Engineering at Imperial College London. Biomedical engineering experience developing biosensors using aptamers, and a drug delivery device for hypertension management.",
      "linkedin": "https://linkedin.com/in/christopher-lau-542798151"
    },
    {
      "name": "Shanil Panara, Founder",
      "description": "Cofounder and in silico lead at Nanograb; Imperial College PhD (dropout); \n\nFascinated by all things compute and physics... all in the name of figuring out real life things!\n\nOtherwise, I love singing and music in general. Fun fact: I was in an a cappella group for 5 years :)",
      "linkedin": "https://linkedin.com/in/shanilpanara"
    }
  ],
  "status": true,
  "markdown": "raw_markdown='[ 0 ](https://nanograb.com/</cart>)\\n[ Skip to Content ](https://nanograb.com/<#page>)\\n[nanograb](https://nanograb.com/</>)\\n[ ![nanograb](https://images.squarespace-cdn.com/content/v1/61eb350049e7a1353f71eb40/65012ccb-f067-4154-808a-8166362e10e0/Nanograb_icon.png?format=1500w) ](https://nanograb.com/</>)\\n[ Team ](https://nanograb.com/</team>)\\nOpen Menu Close Menu\\n[nanograb](https://nanograb.com/</>)\\n[ ![nanograb](https://images.squarespace-cdn.com/content/v1/61eb350049e7a1353f71eb40/65012ccb-f067-4154-808a-8166362e10e0/Nanograb_icon.png?format=1500w) ](https://nanograb.com/</>)\\n[ Team ](https://nanograb.com/</team>)\\nOpen Menu Close Menu\\n[ Team  ](https://nanograb.com/</team>)\\n![](https://images.squarespace-cdn.com/content/v1/61eb350049e7a1353f71eb40/1642811740105-JI3V5EG2EITWQXUZ7R38/unsplash-image-1WKZQb6bB-4.jpg)\\n# Multivalent nanoparticles with next-generation targeting capabilities\\nNanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases. Our product allows drugs to be targeted to very specific areas of the body.\\n![](https://images.squarespace-cdn.com/content/v1/61eb350049e7a1353f71eb40/52180c88-2884-4551-aec7-0dc1cd72d073/movie+%282%29.gif)\\n#### nanograb\\nhello@nanograb.com\\n' markdown_with_citations=' 0 ⟨1⟩\\n Skip to Content ⟨2⟩\\nnanograb⟨3⟩\\n ![nanograb⟨4⟩ ](https://nanograb.com/</>)\\n Team ⟨5⟩\\nOpen Menu Close Menu\\nnanograb⟨3⟩\\n ![nanograb⟨4⟩ ](https://nanograb.com/</>)\\n Team ⟨5⟩\\nOpen Menu Close Menu\\n Team  ⟨5⟩\\n![](https://images.squarespace-cdn.com/content/v1/61eb350049e7a1353f71eb40/1642811740105-JI3V5EG2EITWQXUZ7R38/unsplash-image-1WKZQb6bB-4.jpg)\\n# Multivalent nanoparticles with next-generation targeting capabilities\\nNanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases. Our product allows drugs to be targeted to very specific areas of the body.\\n![](https://images.squarespace-cdn.com/content/v1/61eb350049e7a1353f71eb40/52180c88-2884-4551-aec7-0dc1cd72d073/movie+%282%29.gif)\\n#### nanograb\\nhello@nanograb.com\\n' references_markdown='\\n\\n## References\\n\\n⟨1⟩ https://nanograb.com/</cart>:  0 \\n⟨2⟩ https://nanograb.com/<#page>:  Skip to Content \\n⟨3⟩ https://nanograb.com/</>: nanograb\\n⟨4⟩ https://images.squarespace-cdn.com/content/v1/61eb350049e7a1353f71eb40/65012ccb-f067-4154-808a-8166362e10e0/Nanograb_icon.png?format=1500w:  ![nanograb\\n⟨5⟩ https://nanograb.com/</team>:  Team \\n' fit_markdown='' fit_html=''",
  "generated_description": "**Company Overview: Nanograb**\n\nFounded in 2023, Nanograb is an innovative player in the realm of biotech, specifically focused on drug delivery and computational drug discovery. Based out of San Francisco and part of the Y Combinator Batch S23, Nanograb employs a lean team of three dedicated employees, emphasizing a forward-thinking approach to medical science.\n\n**Mission and Technology**\n\nAt its core, Nanograb aims to enhance targeted drug delivery through the power of artificial intelligence. Their product leverages AI to generate optimal combinations of binders designed to treat various diseases effectively. This technology enables drugs to hone in on very specific parts of the body, potentially improving treatment outcomes while minimizing side effects. It's a classic example of how AI can innovate in life sciences—turning complex problems into manageable solutions.\n\n**Key Features and Offerings**\n\n- **AI-Powered Drug Discovery**: Nanograb utilizes advanced algorithms to create customizable binders, making drug therapy more precise.\n- **Multivalent Nanoparticles**: Their product is centered on cutting-edge nanoparticle technology that enhances targeting capabilities, a real game-changer in drug administration.\n\n**Strategic Positioning**\n\nWith its focus on nanomedicine and therapeutics, Nanograb is well positioned at the intersection of artificial intelligence and biotechnology. It carries tags that reflect its mission and market segment: 'ai-powered-drug-discovery,' 'nanomedicine,' 'biotech,' 'drug-delivery,' and 'therapeutics.' These facets not only define what they do but also act as a beacon for collaborators and investors interested in groundbreaking healthcare solutions.\n\nThe group's advisor is simply noted as \"nan,” which suggests a focus on building strategic partnerships within the biotech community.\n\n**Conclusion**\n\nIn a world where drug delivery systems often fall short, Nanograb is set to redefine how treatments are targeted and administered. With a clear mission, a cutting-edge approach, and the backing from Y Combinator, they are poised to make significant waves in the biotech industry. If harnessed correctly, their discoveries could lead to breakthroughs in how we approach treatment for a range of diseases. For more information, visit their website at [Nanograb](https://nanograb.com)."
}